David Marais

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia

Katherine Wilemon, Jasmine Patel, Carlos A. Aguilar‐Salinas et al. · JAMA Cardiology · 2020 · 258 citations · Full text

Medicine, Cardiology, Preventive Medicine +15

Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance

Maura Agostini, Erik Schoenmakers, Catherine Mitchell et al. · Cell Metabolism · 2006 · 182 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Chronic melatonin consumption prevents obesity‐related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet‐induced obesity

Frederic Nduhirabandi, Eugene F. Du Toit, Dee Blackhurst et al. · Journal of Pineal Research · 2010 · 145 citations · Full text

Medicine, Pharmacology, Physiology +17

A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension

Brian Rayner, E.P. Owen, Judy A. King et al. · Journal of Hypertension · 2003 · 83 citations

Medicine, Genetics, Molecular Genetics +14

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

M Jeenah, Wesley September, Frans Graadt van Roggen et al. · Atherosclerosis · 1993 · 71 citations

Life Sciences, Genetics, Pharmacology +14